Atara Biotherapeutics, Inc. - Common Stock (ATRA)

CUSIP: 046513107

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / Common Stock
Shares outstanding
8,165,808
Total 13F shares
85,650,758
Share change
+59,612
Total reported value
$1,229,931,921
Put/Call ratio
30%
Price per share
$14.36
Number of holders
148
Value change
-$3,128,334
Number of buys
80
Number of sells
60

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 046513107?
CUSIP 046513107 identifies ATRA - Atara Biotherapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q1 2021

As of 31 Mar 2021, Atara Biotherapeutics, Inc. - Common Stock (ATRA) was held by 148 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 85,650,758 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, BlackRock Inc., Redmile Group, LLC, MAVERICK CAPITAL LTD, JPMORGAN CHASE & CO, VANGUARD GROUP INC, STATE STREET CORP, MORGAN STANLEY, CREDIT SUISSE AG/, and GOLDMAN SACHS GROUP INC. This page lists 148 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders
144
Q1 2021 holders
148
Holder diff
4
Investor Q4 2020 Shares Q1 2021 Shares Share Diff Share Chg % Q4 2020 Value $ Q1 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.